Model DetailsLeukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma
Model Name |
Leukocyte - Monocyte - Macrophage - Histiocyte histiocytic sarcoma | Strain |
(C57BL/6N x C3H/HeN)F1 |
Tumor Inducing Agent(s) |
None (spontaneous) |
Tumor Synonyms |
histiocytic sarcoma • hematopoietic/lymphoreticular system, histiocytic sarcoma |
Strain Synonyms |
BCF1 • B6C3F1 • C57BL/6NxC3H/HeN F1 • B6C3F1 • (C57BL/6N X C3H/HeN)F1 |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
3.8% (8 of 213 mice) |
120 weeks |
|
Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
4.7% (10 of 213 mice) |
120 weeks |
|
Dasenbrock C, Exp Toxicol Pathol 2005 Apr;56(6):351-60 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 41 mice) |
12-24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
7.1% (1 of 14 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
1.4% (1 of 70 mice) |
12-36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
9.4% (3 of 32 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
7.5% (3 of 40 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
9.6% (7 of 73 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
15.8% (3 of 19 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
9.8% (13 of 132 mice) |
12-36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 16 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 22 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
5.9% (1 of 17 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
0% (0 of 1 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
1.8% (1 of 56 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Female |
5.8% (15 of 258 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 43 mice) |
12-24 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 15 mice) |
30 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 15 mice) |
36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 73 mice) |
12-36 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
5.3% (1 of 19 mice) |
24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
3.6% (1 of 28 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
14.9% (7 of 47 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
5.9% (2 of 34 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
28.6% (2 of 7 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
10.3% (12 of 116 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 11 mice) |
12-24 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
9.5% (2 of 21 mice) |
30 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
18.75% (3 of 16 mice) |
36 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
0% (0 of 8 mice) |
42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
8.9% (5 of 56 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |
| Leukocyte - Monocyte - Macrophage - Histiocyte | Male |
6.9% (17 of 245 mice) |
12-42 +/- 3 months |
|
Sheldon WG, Toxicol Pathol 1995 Jul-Aug;23(4):458-76 |